561 related articles for article (PubMed ID: 15264268)
1. Inherited predisposition to cancer: a historical overview.
Lynch HT; Shaw TG; Lynch JF
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
[TBL] [Abstract][Full Text] [Related]
2. Familial pancreatic cancer.
Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis.
Güran S; Ozet A; Dede M; Gille JJ; Yenen MC
Cancer Genet Cytogenet; 2005 Jul; 160(2):164-8. PubMed ID: 15993273
[TBL] [Abstract][Full Text] [Related]
4. Hereditary cancer in adults.
Lynch HT; Fusaro RM; Lynch J
Cancer Detect Prev; 1995; 19(3):219-33. PubMed ID: 7750110
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
6. Hereditary cancer syndrome diagnosis: molecular genetic clues and cancer control.
Lynch HT; Fusaro RM; Lynch JF
Future Oncol; 2007 Apr; 3(2):169-81. PubMed ID: 17381417
[TBL] [Abstract][Full Text] [Related]
7. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing for cancer predisposition.
Eng C; Hampel H; de la Chapelle A
Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
[TBL] [Abstract][Full Text] [Related]
9. The genetics of hereditary colon cancer.
Rustgi AK
Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.
Nagore E; Montoro A; García-Casado Z; Botella-Estrada R; Insa A; Lluch A; López-Guerrero JA; Guillén C
Melanoma Res; 2009 Aug; 19(4):211-4. PubMed ID: 19571771
[TBL] [Abstract][Full Text] [Related]
11. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
12. Hereditary common cancers: molecular and clinical genetics.
Russo A; Zanna I; Tubiolo C; Migliavacca M; Bazan V; Latteri MA; Tomasino RM; Gebbia N
Anticancer Res; 2000; 20(6C):4841-51. PubMed ID: 11205230
[TBL] [Abstract][Full Text] [Related]
13. Can we identify the high-risk patients to be screened? A genetic approach.
Gammon A; Kohlmann W; Burt R
Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
[TBL] [Abstract][Full Text] [Related]
14. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
[TBL] [Abstract][Full Text] [Related]
15. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
16. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
17. Hereditary ovarian cancer.
Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
[TBL] [Abstract][Full Text] [Related]
18. Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
Cederquist K; Emanuelsson M; Wiklund F; Golovleva I; Palmqvist R; Grönberg H
Clin Genet; 2005 Dec; 68(6):533-41. PubMed ID: 16283884
[TBL] [Abstract][Full Text] [Related]
19. Inherited cancer susceptibility syndromes in paediatric practice.
Field M; Shanley S; Kirk J
J Paediatr Child Health; 2007 Apr; 43(4):219-29. PubMed ID: 17444822
[TBL] [Abstract][Full Text] [Related]
20. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]